Integra Lifesciences Overview
- Year Founded
-
1989

- Status
-
Public
- Employees
-
4,396

- Stock Symbol
-
IART

- Investments
-
51
- Share Price
-
$11.91
- (As of Wednesday Closing)
Integra Lifesciences General Information
Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Contact Information
Website
www.integralife.comCorporate Office
- 1100 Campus Road
- Princeton, NJ 08540
- United States
Corporate Office
- 1100 Campus Road
- Princeton, NJ 08540
- United States
Integra Lifesciences Stock Performance
As of 18-Jun-2025, Integra Lifesciences’s stock price is $11.91. Its current market cap is $926M with 77.7M shares.
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$11.91 | $12.15 | $11.60 - $32.66 | $926M | 77.7M | 1.15M | -$0.38 |
Integra Lifesciences Financials Summary
As of 31-Mar-2025, Integra Lifesciences has a trailing 12-month revenue of $1.62B.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 3,409,040 | 3,461,915 | 4,818,305 | 5,885,339 |
Revenue | 1,624,308 | 1,610,527 | 1,541,573 | 1,557,666 |
EBITDA | 160,876 | 179,955 | 238,944 | 369,971 |
Net Income | (28,955) | (6,944) | 67,741 | 180,550 |
Total Assets | 4,052,751 | 4,037,424 | 3,781,988 | 3,889,758 |
Total Debt | 2,018,937 | 1,984,563 | 1,681,682 | 1,615,359 |
Integra Lifesciences Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Integra Lifesciences Comparisons
Industry
Financing
Details
Integra Lifesciences Competitors (28)
One of Integra Lifesciences’s 28 competitors is Orthofix International, a Formerly PE-Backed company based in Lewisville, TX.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Orthofix International | Formerly PE-Backed | Lewisville, TX | ||||
Mimedx Group | Corporation | Marietta, GA | ||||
Zimmer Biomet Holdings | Corporation | Warsaw, IN | ||||
SeaSpine Holdings | Corporate Backed or Acquired | Carlsbad, CA | ||||
Apyx Medical | Corporation | Clearwater, FL |
Integra Lifesciences Patents
Integra Lifesciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250032627-A1 | Therapeutic sealants based upon drug conjugates | Pending | 14-Jul-2023 | ||
US-D1040168-S1 | Display screen with an animated graphical user interface | Active | 06-Jul-2022 | ||
US-D1053889-S1 | Display screen with a graphical user interface | Active | 06-Jul-2022 | ||
US-12059509-B1 | Method and matrix for tissue regeneration | Active | 05-May-2020 | ||
US-20210308330-A1 | Devices and methods for nerve regeneration | Active | 06-Apr-2020 | A61L27/3675 |
Integra Lifesciences Signals
Integra Lifesciences Investments & Acquisitions (51)
Integra Lifesciences’s most recent deal was a Corporate Asset Purchase with Integra Lifesciences (Manufacturing Facility in Plainsboro, New Jersey) for
. The deal was made on 01-Oct-2024.Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Integra Lifesciences (Manufacturing Facility in Plainsboro, New Jersey) | 01-Oct-2024 | Corporate Asset Purchase | Buildings and Property | ||
Acclarent | 01-Apr-2024 | Merger/Acquisition | Surgical Devices | ||
Surgical Innovation Associates | 06-Dec-2022 | Merger/Acquisition | Surgical Devices | ||
ACell | 20-Jan-2021 | Merger/Acquisition | Surgical Devices | ||
Rebound Therapeutics | 09-Sep-2019 | Merger/Acquisition | Surgical Devices |
Integra Lifesciences ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
22.81 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile

Healthcare
Industry
of 564
Rank
Percentile

Medical Devices
Subindustry
of 196
Rank
Percentile

Integra Lifesciences Exits (6)
Integra Lifesciences’s most recent exit was on 24-Feb-2017 from Derma Sciences. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Derma Sciences | 24-Feb-2017 | Completed |
|
||
Avraham Pharma | 25-Feb-2016 | Completed |
|
||
Avraham Pharma | 17-Sep-2014 | Completed |
|
||
SeaSpine Holdings | 23-May-2011 | Completed |
|
||
Welch Allyn | 01-May-2010 | Merger/Acquisition | Completed |
Integra Lifesciences Affiliates
Subsidiaries (4)
Name | Industry | Location | Year Founded |
---|---|---|---|
Surgical Innovation Associates | Chicago, IL | 2016 | |
Integra Spine | Akron, OH | 1998 | |
Miltex Dental | York, PA | ||
NMT Medical (Three Product Lines) | Plainsboro Center, NJ |
Integra Lifesciences FAQs
-
When was Integra Lifesciences founded?
Integra Lifesciences was founded in 1989.
-
Where is Integra Lifesciences headquartered?
Integra Lifesciences is headquartered in Princeton, NJ.
-
What is the size of Integra Lifesciences?
Integra Lifesciences has 4,396 total employees.
-
What industry is Integra Lifesciences in?
Integra Lifesciences’s primary industry is Surgical Devices.
-
Is Integra Lifesciences a private or public company?
Integra Lifesciences is a Public company.
-
What is Integra Lifesciences’s stock symbol?
The ticker symbol for Integra Lifesciences is IART.
-
What is the current stock price of Integra Lifesciences?
As of 18-Jun-2025 the stock price of Integra Lifesciences is $11.91.
-
What is the current market cap of Integra Lifesciences?
The current market capitalization of Integra Lifesciences is $926M.
-
What is Integra Lifesciences’s current revenue?
The trailing twelve month revenue for Integra Lifesciences is $1.62B.
-
Who are Integra Lifesciences’s competitors?
Orthofix International, Mimedx Group, Zimmer Biomet Holdings, SeaSpine Holdings, and Apyx Medical are some of the 28 competitors of Integra Lifesciences.
-
What is Integra Lifesciences’s annual earnings per share (EPS)?
Integra Lifesciences’s EPS for 12 months was -$0.38.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »